RESISTANCE TO FLT3 INHIBITORS IN ACUTE MYELOID LEUKEMIA: MOLECULAR MECHANISMS AND RESENSITIZING STRATEGIES
10.5306/wjco.v9.i5.90
Saved in:
Main Authors: | Zhou, J, CHNG WEE JOO |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Review |
Published: |
Baishideng Publishing Group Inc.
2019
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/155351 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor
by: Zhou, J., et al.
Published: (2011) -
In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor
by: Zhou, J., et al.
Published: (2011) -
In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor
by: Zhou, J., et al.
Published: (2011) -
In vitro and in vivo study of ABT-869 in treatment acute myeloid leukemia (AML) alone or in combination with chemotherapy or HDAC inhibitors: insight into molecular mechanism and biologic characterization
by: ZHOU JIANBIAO
Published: (2010) -
MECHANISMS OF HYPOXIA-INDUCED GROWTH AND TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKEMIA
by: MANJERI ADITI SUBRAMANIAM
Published: (2019)